PL376130A1 - System o kontrolowanym uwalnianiu obejmujący temozolomid - Google Patents

System o kontrolowanym uwalnianiu obejmujący temozolomid

Info

Publication number
PL376130A1
PL376130A1 PL03376130A PL37613003A PL376130A1 PL 376130 A1 PL376130 A1 PL 376130A1 PL 03376130 A PL03376130 A PL 03376130A PL 37613003 A PL37613003 A PL 37613003A PL 376130 A1 PL376130 A1 PL 376130A1
Authority
PL
Poland
Prior art keywords
system containing
controlled releases
releases system
containing temozolomide
temozolomide
Prior art date
Application number
PL03376130A
Other languages
English (en)
Other versions
PL218200B1 (pl
Inventor
Yongfeng Wang
Dan Fei
Original Assignee
Tianjin Tasly Group Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Group Co, Ltd. filed Critical Tianjin Tasly Group Co, Ltd.
Publication of PL376130A1 publication Critical patent/PL376130A1/pl
Publication of PL218200B1 publication Critical patent/PL218200B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Niniejszy wynalazek dotyczy systemu o kontrolowanym uwalnianiu, w szczególności systemu o kontrolowanym uwalnianiu zawierającego temozolomid.
PL376130A 2002-09-29 2003-09-29 System o kontrolowanym uwalnianiu obejmujący temozolomid oraz sposób wytwarzania tabletek temozolomidu o kontrolowanym uwalnianiu PL218200B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN02131347 2002-09-29

Publications (2)

Publication Number Publication Date
PL376130A1 true PL376130A1 (pl) 2005-12-27
PL218200B1 PL218200B1 (pl) 2014-10-31

Family

ID=32034727

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376130A PL218200B1 (pl) 2002-09-29 2003-09-29 System o kontrolowanym uwalnianiu obejmujący temozolomid oraz sposób wytwarzania tabletek temozolomidu o kontrolowanym uwalnianiu

Country Status (15)

Country Link
US (1) US8821913B2 (pl)
EP (1) EP1550444A4 (pl)
JP (1) JP4879488B2 (pl)
KR (1) KR100979217B1 (pl)
CN (1) CN100366249C (pl)
AU (1) AU2003272857B2 (pl)
BR (1) BR0314838A (pl)
CA (1) CA2500387C (pl)
MX (1) MXPA05003315A (pl)
NZ (1) NZ539527A (pl)
PL (1) PL218200B1 (pl)
RU (1) RU2322979C2 (pl)
UA (1) UA87813C2 (pl)
WO (1) WO2004028534A1 (pl)
ZA (1) ZA200502858B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100431608C (zh) * 2005-04-06 2008-11-12 山东蓝金生物工程有限公司 一种含四嗪类化合物的抗实体肿瘤药物组合物
CN101559037B (zh) * 2008-04-16 2013-01-30 北京京卫燕康药物研究所有限公司 用于静脉和脑内注射的两元溶液型制剂
US9316632B2 (en) * 2009-03-17 2016-04-19 Marshall University Research Corporation Methods of screening chemotherapeutic agents and treating cancer
US20120171118A1 (en) * 2009-06-12 2012-07-05 The General Hospital Corporation Treatment of meningeal and neural diseases
CN101869551B (zh) * 2010-06-28 2012-04-18 江苏奥赛康药业股份有限公司 一种替莫唑胺冻干制剂
CN102406627B (zh) * 2011-11-22 2013-03-13 温州医学院 一种层层组装马赛克结构药物缓释植片
CN104324014A (zh) * 2014-11-25 2015-02-04 深圳市健元医药科技有限公司 一种含醋酸卡泊芬净的药物组合物缓释植入剂及其制备
CA2993823C (en) 2015-07-28 2024-01-02 Board Of Regents, The University Of Texas System Implant compositions for the unidirectional delivery of therapeutic compounds to the brain
CN108403656A (zh) * 2018-04-03 2018-08-17 孙奉生 一种用于治疗多形性胶质母细胞瘤的替莫唑胺多晶型胶囊
US20200129435A1 (en) * 2018-10-24 2020-04-30 Uvic Industry Partnerships Inc. Composition for delivering a therapeutic agent and methods for making and using

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888176A (en) * 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
CZ286550B6 (cs) * 1993-01-14 2000-05-17 Cancer Research Campaign Technology Ltd. Kombinovaný farmaceutický prostředek pro léčbu lidských nádorových buněk, použití inhibitoru ATasy a temozolomidu pro jeho přípravu a souprava
US5633000A (en) 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
AU9376998A (en) * 1997-09-02 1999-03-22 Johns Hopkins University School Of Medicine, The Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
CN1345240A (zh) * 1999-03-30 2002-04-17 先灵公司 用替莫唑胺改善癌症治疗
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
JP4144980B2 (ja) * 1999-09-22 2008-09-03 オリンパス株式会社 ステージ装置
US6647412B1 (en) 2000-06-23 2003-11-11 Nokia Internet Communications Inc. Method and network for propagating status information
CA2420854C (en) * 2000-09-01 2013-07-30 Palmaya Pty Ltd Slow release pharmaceutical preparation and method of administering of same
US20020128228A1 (en) * 2000-12-01 2002-09-12 Wen-Jen Hwu Compositions and methods for the treatment of cancer

Also Published As

Publication number Publication date
EP1550444A4 (en) 2010-05-26
JP4879488B2 (ja) 2012-02-22
AU2003272857B2 (en) 2008-08-07
KR100979217B1 (ko) 2010-08-31
UA87813C2 (ru) 2009-08-25
NZ539527A (en) 2007-10-26
MXPA05003315A (es) 2005-10-18
BR0314838A (pt) 2005-08-09
CN100366249C (zh) 2008-02-06
RU2322979C2 (ru) 2008-04-27
ZA200502858B (en) 2008-01-30
US20050244494A1 (en) 2005-11-03
US8821913B2 (en) 2014-09-02
CA2500387A1 (en) 2004-04-08
RU2005113282A (ru) 2005-10-10
CA2500387C (en) 2012-07-10
PL218200B1 (pl) 2014-10-31
KR20050072094A (ko) 2005-07-08
EP1550444A1 (en) 2005-07-06
JP2006504698A (ja) 2006-02-09
CN1600307A (zh) 2005-03-30
AU2003272857A1 (en) 2004-04-19
WO2004028534A1 (fr) 2004-04-08

Similar Documents

Publication Publication Date Title
DK1553929T3 (da) Sammensætning med kontrolleret frigivelse.
ITTO20010923A0 (it) Fibbia.
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
EP1390991A4 (en) Active devices using threads
NO20053248D0 (no) Kerosenblanding.
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
PL376130A1 (pl) System o kontrolowanym uwalnianiu obejmujący temozolomid
NO20052248D0 (no) Svivelstykkesystem.
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
NO20052680D0 (no) Forbedringsmiddel inneholdende brennstoff.
IT1315996B1 (it) Apparecchio per alimentazione di emergenza.
ES1048305Y (es) Hebilla autoblocante.
ES1056134Y (es) Hebilla.
ES1052590Y (es) Quiosco-consigna.
ITMI20020288A1 (it) Do.re.mi
ES1052628Y (es) Extintor instantaneo.
ITTO20020112V0 (it) ,,portafogli,,.
MA25629A1 (fr) Reacteur : aero-hydro-electrique.
ES1052724Y (es) Mochila.
ITCZ20020010A1 (it) Spaccalegna.
ES1052011Y (es) Espetero.
ES1052654Y (es) Cubitera.
ES1052938Y (es) Cantonera.
ES1052945Y (es) Contraventana.